IN THE SECOND QUARTER OF 2024, in vitro diagnostics (IVD) companies reported solid revenues as well as new tests, analyzers, and automation. Most of the IVD companies boosted diagnostic sales in low single digit amounts. During the earnings calls, financial analysts asked company leaders about growth they may see in 2025. Overall, with the decline …
Global IVD Companies Report Second Quarter 2024 Earnings Read More »
